SCHEMBL21569983

SCHEMBL21569983

CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)COC(=O)CN)O1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 12/20 0.79
▸ PGR P06401 7/20 0.79
▸ CYP3A4 P08684 3/20 0.79
▸ HIF1A Q16665 2/20 0.79
▸ ABCC3 O15438 1/20 0.79
▸ ABCC4 O15439 1/20 0.79
▸ ABCB11 O95342 1/20 0.79
▸ IL5 P05113 1/20 0.79
▸ NR3C2 P08235 1/20 0.79
▸ AR P10275 1/20 0.79
▸ CHRM1 P11229 1/20 0.79
▸ MMP9 P14780 1/20 0.79
▸ NFKB1 P19838 1/20 0.79
▸ THPO P40225 1/20 0.79
▸ SMN1; SMN2 Q16637 1/20 0.79
▸ HSD17B10 Q99714 1/20 0.79
▸ LMNA P02545 1/20 0.79
▸ BLM P54132 1/20 0.79
▸ PMP22 Q01453 1/20 0.79
▸ NPSR1 Q6W5P4 1/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27072506 1.00 NR3C1 (0.79) NR3C1PGRCYP3A4HIF1AABCC3
SCHEMBL5396842 0.94 NR3C1 (0.81) NR3C1PGRCYP3A4HIF1AABCC3
SCHEMBL4448853 0.92 NR3C1 (0.82) NR3C1PGRCYP3A4HIF1AABCC3
SCHEMBL7735898 0.92 ALDH1A1 (0.84) NR3C1PGRCYP3A4HIF1AABCC3
SCHEMBL7751385 0.92 ALDH1A1 (0.84) NR3C1PGRCYP3A4HIF1AABCC3
SCHEMBL17151413 0.92 ALDH1A1 (0.84) NR3C1PGRCYP3A4HIF1AABCC3
SCHEMBL20149285 0.92 NR3C1 (0.87) NR3C1PGRCYP3A4HIF1AABCC3
SCHEMBL20223501 0.92 NR3C1 (0.87) NR3C1PGRCYP3A4HIF1AABCC3
SCHEMBL21569872 0.92 NR3C1 (0.87) NR3C1PGRCYP3A4HIF1AABCC3
SCHEMBL20149516 0.92 NR3C1 (0.87) NR3C1PGRCYP3A4HIF1AABCC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019217591-A1 ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2019-11-14 — — WO disclosed
Send feedback